GHP Investment Advisors Inc. decreased its position in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) by 3.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 84,023 shares of the technology company's stock after selling 3,045 shares during the period. GHP Investment Advisors Inc. owned about 0.31% of Plexus worth $13,148,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Blue Trust Inc. raised its holdings in Plexus by 12.1% during the fourth quarter. Blue Trust Inc. now owns 776 shares of the technology company's stock worth $121,000 after purchasing an additional 84 shares in the last quarter. Glenmede Trust Co. NA increased its position in Plexus by 4.4% during the 3rd quarter. Glenmede Trust Co. NA now owns 2,453 shares of the technology company's stock worth $335,000 after purchasing an additional 104 shares during the period. GAMMA Investing LLC raised its stake in shares of Plexus by 17.2% during the 4th quarter. GAMMA Investing LLC now owns 891 shares of the technology company's stock worth $139,000 after buying an additional 131 shares in the last quarter. Farrow Financial Inc. lifted its holdings in shares of Plexus by 0.7% in the 3rd quarter. Farrow Financial Inc. now owns 21,692 shares of the technology company's stock valued at $2,966,000 after buying an additional 155 shares during the period. Finally, Quarry LP boosted its stake in shares of Plexus by 573.5% in the third quarter. Quarry LP now owns 229 shares of the technology company's stock valued at $31,000 after buying an additional 195 shares in the last quarter. 94.45% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several research firms have issued reports on PLXS. Needham & Company LLC increased their price objective on Plexus from $162.00 to $172.00 and gave the stock a "buy" rating in a research report on Friday, January 24th. StockNews.com upgraded shares of Plexus from a "hold" rating to a "buy" rating in a research note on Monday, November 18th. Stifel Nicolaus began coverage on shares of Plexus in a research report on Tuesday, February 4th. They set a "hold" rating and a $152.00 target price on the stock. KeyCorp initiated coverage on shares of Plexus in a research report on Tuesday, October 22nd. They set a "sector weight" rating for the company. Finally, Benchmark restated a "buy" rating and issued a $165.00 price target on shares of Plexus in a report on Wednesday, January 22nd. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $163.00.
Check Out Our Latest Research Report on Plexus
Insider Activity
In other news, CEO Todd P. Kelsey sold 4,337 shares of the business's stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $142.23, for a total transaction of $616,851.51. Following the completion of the sale, the chief executive officer now directly owns 80,595 shares of the company's stock, valued at $11,463,026.85. The trade was a 5.11 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Michael J. Running sold 539 shares of Plexus stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $155.87, for a total value of $84,013.93. Following the completion of the transaction, the insider now owns 1,030 shares in the company, valued at $160,546.10. The trade was a 34.35 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,239 shares of company stock valued at $2,212,730 over the last 90 days. Insiders own 1.76% of the company's stock.
Plexus Price Performance
Shares of NASDAQ PLXS traded up $0.63 on Monday, hitting $141.76. The company's stock had a trading volume of 146,539 shares, compared to its average volume of 178,630. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.53 and a quick ratio of 0.70. The stock has a 50 day moving average of $158.56 and a 200-day moving average of $144.08. Plexus Corp. has a 12-month low of $90.18 and a 12-month high of $172.89. The company has a market capitalization of $3.83 billion, a price-to-earnings ratio of 32.89 and a beta of 0.89.
Plexus (NASDAQ:PLXS - Get Free Report) last announced its earnings results on Wednesday, January 22nd. The technology company reported $1.49 EPS for the quarter, missing analysts' consensus estimates of $1.59 by ($0.10). Plexus had a net margin of 3.03% and a return on equity of 10.36%. As a group, research analysts predict that Plexus Corp. will post 5.94 EPS for the current year.
Plexus Profile
(
Free Report)
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Featured Stories

Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.